The Egyptian Drug Authority (EDA) has released the first part of its guidance titled "Role of Oncology Pharmacist in Precision Medicine." This guide is tailored for pharmacists working in specialized oncology healthcare institutions. Its primary objective is to equip them with essential knowledge and practical insights into precision medicine, enabling them to effectively support oncology patients by understanding the field’s goals, tools, applications, and future trends. Furthermore, it empowers oncology pharmacists to collaborate within multidisciplinary care teams to optimize medication management and enhance clinical outcomes through personalized therapeutic strategies.

The guidance provides a comprehensive overview of the principles, tools, and applications of precision medicine in oncology, with a specific focus on the evolving role of the pharmacist. This initiative stems from the EDA’s vision and its leading role in advancing pharmaceutical services and elevating the professional competence of Egyptian pharmacists. These efforts aim to enhance and standardize pharmacy practices, continuing the EDA’s mission to issue professional guidelines and establish benchmarks for the pharmacist's role as a cornerstone of the healthcare system.

"The guidance document is available for review through the Egyptian Drug Authority (EDA) Official Website."